The Biomedical Advanced Research and Development Authority (BARDA) has launched an $80+ million multi-stage competition for “vaccine developers and researchers, biotech companies, and other innovators” to develop vaccines for pandemic influenza A, or A(H5) bird flu, which includes highly pathogenic avian influenza A(H5N1). The name of the competition is Single Shield Prize, and it “calls for innovative solutions enabling the development of vaccines that could provide protection in only one visit,” promising award winners “access to technical support and opportunities to connect with collaborators, industry partners, and potential investors.”1
The Single Shield Prize is managed by Luminary Labs, a New York City-based strategy and innovation consultancy that helps public-sector organizations “solve complex problems in complex industries.”2 The prize is divided into three stages and allows up to eight winners to receive up to $4 million each during the first stage. The second stage provides up to $8 million each for up to four winners. The third stage, IND Readiness, is intended to move successful vaccine candidates toward preparation for an Investigational New Drug (IND) application that could then proceed to human clinical testing.3
$80 Million Prize Pool for H5N1 Vaccine Development Tied to $5 Billion Taxpayer-Funded Project NextGen
According to a 2025 announcement from Luminary Labs about previous BARDA prize winners, the over $80 million prize pool for the Single Shield project was funded “in whole or in part with federal funds” from the U.S. Department of Health and Human Services (DHHS), the Administration for Strategic Preparedness and Response (ASPR) and BARDA. During the 2025 announcement, Luminary Labs introduced the Single Shield Prize, calling it a “forthcoming prize to advance H5N1 vaccines that could be administered in only one visit.”4
The Single Shield Prize was launched through Project NextGen, a $5 billion initiative announced in 2023 to develop “next-generation” COVID-19 shots and therapeutics.5 In 2025, the DHHS halted funding for several Project NextGen vaccine development projects, issuing stop-work orders to several biotech firms, requiring them to immediately halt work and actively minimize additional costs related to the project. Two of the firms that received stop-work orders, GeoVax and CastleVax, said at the time they planned to move forward without the federal funding.6
Critics Question Government Funding of H5N1 Vaccine Development Before a Pandemic is Declared
Critics of the Single Shield Prize have questioned the federal government’s decision to finance development of vaccines for a potential H5N1 pandemic before such a pandemic has been declared. Investigative writer and independent analyst Jon Fleetwood said in a Sept. 21 Substack post discussing BARDA’s Single Shield Prize, “The emergency may only exist in the government’s prediction, but part of the machinery that would respond to it is already being funded and built.”7
He continued, “That raises the questions our pandemic-orchestration reporting has been asking for years:
- How much of a future pandemic response is constructed before the emergency?
- Who decides when this pre-positioned machinery is activated?
- What evidence must justify that activation?
- And how much money is now flowing into an H5N1 response across BARDA, HHS, USDA, DoD, and other federal programs before any H5N1 pandemic has been declared?”8
Former CDC Director Warned of “Imminent” Bird Flu Pandemic in 2024
Former director of the U.S. Centers for Disease Control and Prevention (CDC) Robert Redfield, MD issued a warning in 2024 that a bird flu pandemic was “imminent.” The warning came as H5N1 was spreading among cattle herds in the U.S. and reports of H5N1 infections in humans began to surface. Redfield expressed concern over the growing number of human infections in the U.S. at the time.9
“I really do think it’s very likely that we will, at some time, it’s not a question of if, it’s more a question of when we will have a bird flu pandemic,” Dr. Redfield said. “Once the virus acquires the capability to attach to human receptors and transmit from person to person, that’s when a pandemic will occur. As I mentioned, I believe it’s just a matter of time.”10
“The government does not need an H5N1 pandemic to begin building the pharmaceutical response to one. It is paying to build that response in advance. Just like it did before the COVID-19 pandemic,” Fleetwood stated.11
The CDC reports as of May 2026 that A(H5) Bird Flu is widespread in wild birds worldwide, has caused outbreaks in poultry and U.S. dairy cows with sporadic human cases primarily in dairy and poultry workers. The CDC states that the current public health risk is low, with no known person-to-person spread at this time.12
If you would like to receive an e-mail notice of the most recent articles published in The Vaccine Reaction each week, click here.
Click here to view References:1 Advanced Research Projects Agency for Health. Single Shield Prize – About the Prize. Sept. 25, 2026.
2 Luminary Labs. About Luminary Labs. Sept. 25, 2026.
3 Advanced Research Projects Agency for Health. Single Shield Prize – About the Prize. Sept. 25, 2026.
4 Luminary Labs. Celebrating New Milestones in Vaccine Innovation. Jan. 16, 2025.
5 Baker A. U.S. Taxpayers Fund $5 Billion Project NextGen to Develop Novel COVID Vaccines and Drugs. The Vaccine Reaction Sept. 4, 2023.
6 Baker A. HHS Halts Funding for Development of Next Generation COVID Biologics. The Vaccine Reaction May 7, 2025.
7 Fleetwood J. BARDA Puts $80 Million-Plus Behind One-Shot H5N1 Vaccine Push Before a Pandemic Exists. Substack Sept. 21, 2026.
8 Ibid.
9 Baker A. Former CDC Director Warns of “Imminent” Bird Flu Pandemic. The Vaccine Reaction July 2, 2024.
10 Ibid.
11 Fleetwood J. BARDA Puts $80 Million-Plus Behind One-Shot H5N1 Vaccine Push Before a Pandemic Exists. Substack Sept. 21, 2026.
12 U.S. Centers for Disease Control and Prevention. H5 Bird Flu: Current Situation. Sept. 12, 2026.
